1.745

1.05% 0.0033

After Hours: 1.71 -0.035 -2.01%

Beyondspring Inc (BYSI)

Overview News Price History Option Chain Discussions Forecast

Beyondspring Inc stock is traded at $1.745, with a volume of 4,983. It is up +1.05% in the last 24 hours and up +1.15% over the past month. BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.

Previous Close:

$1.7417

Open:

$1.73

24h Volume:

4,983

Relative Volume:

0.26

Market Cap:

$70.36M

Revenue:

$1.88M

Net Income/Loss:

$-15.57M

P/E Ratio:

-4.3625

EPS:

-0.4

Net Cash Flow:

$-50.09M

1W Performance:

+3.53%

1M Performance:

+1.15%

6M Performance:

-8.81%

1Y Performance:

-35.06%

1-Day Range:

$1.7059

$1.77

1-Week Range:

$1.6234

$1.77

52-Week Range:

$0.98

$2.974

Beyondspring Inc Stock (BYSI) Company Profile

Name

Beyondspring Inc

Sector

Healthcare (1178)

Industry

Biotechnology (671)

Phone

646-528-4184

Address

100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, FLORHAM PARK, NY

Employee

Twitter

@BeyondSpringInc

Next Earnings Date

2024-08-05

Latest SEC Filings

BYSI's Discussions on Twitter

Compare BYSI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BYSI Beyondspring Inc	1.745	67.73M	1.88M	-15.57M	-50.09M	-0.40
ONC Beone Medicines Ltd Adr	245.58	25.81B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	441.85	111.46B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.35	40.37M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	81.16	6.19B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	489.52	64.44B	14.09B	4.50B	2.96B	39.28

Beyondspring Inc Stock (BYSI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-21	Downgrade	BofA Securities	Buy → Underperform
Dec-02-21	Downgrade	Jefferies	Buy → Hold
Dec-01-21	Downgrade	H.C. Wainwright	Buy → Neutral
Dec-01-21	Downgrade	William Blair	Outperform → Mkt Perform
Sep-09-21	Initiated	Robert W. Baird	Outperform
Aug-04-21	Upgrade	H.C. Wainwright	Neutral → Buy
Apr-05-21	Downgrade	H.C. Wainwright	Buy → Neutral
Jan-11-21	Initiated	BofA Securities	Buy
Dec-29-20	Initiated	Evercore ISI	Outperform
Feb-07-20	Initiated	Jefferies	Buy
Jan-10-20	Initiated	Nomura	Buy
Dec-03-19	Initiated	William Blair	Outperform
Jul-10-19	Reiterated	H.C. Wainwright	Buy
Apr-30-19	Downgrade	Maxim Group	Buy → Hold
Oct-25-18	Reiterated	Maxim Group	Buy

View All

Beyondspring Inc Stock (BYSI) Latest News

May 28, 2025

BeyondSpring Announces Poster Presentation at 2025 ASCO Annual Meeting | BYSI Stock News - GuruFocus

May 28, 2025

BeyondSpring Announces Poster Presentation at 2025 ASCO Annual Meeting - GlobeNewswire

May 28, 2025

BeyondSpring and Merck's Triple Therapy Shows Promise in Advanced Lung Cancer After Immunotherapy Failure - Stock Titan

May 28, 2025

May 23, 2025

Neutropenia Drugs Market Revenue to Surpass USD 24.2 Billion by 2033 with 4.7% CAGR - openPR.com

May 23, 2025

May 22, 2025

BeyondSpring Reports First?Quarter 2025 Financial Results and Provides Corporate Update | BYSI Stock News - GuruFocus

May 12, 2025

BeyondSpring Inc. Reports Positive Early Results for Plinabulin in Metastatic Cancer and Updates on SEED Therapeutics' Progress - Nasdaq

May 12, 2025

BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 12, 2025

May 08, 2025

BeyondSpring, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire

May 08, 2025

May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025

Apr 29, 2025

SEED Therapeutics Secures FDA Rare Pediatric and Orphan Drug Designations for ST-01156 - MSN

Apr 29, 2025

Apr 10, 2025

BeyondSpring (NASDAQ:BYSI) Shares Pass Below 50 Day Moving AverageTime to Sell? - MarketBeat

Apr 10, 2025

Apr 04, 2025

BeyondSpring stock hits 52-week low at $1.34 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

BeyondSpring stock hits 52-week low at $1.34 amid market challenges - Investing.com India

Apr 04, 2025

Mar 30, 2025

BeyondSpring (NASDAQ:BYSI) Trading Down 3.8%Here's Why - MarketBeat

Mar 30, 2025

Mar 29, 2025

BeyondSpring’s 2024 Progress and Strategic Milestones - TipRanks

Mar 29, 2025

Mar 28, 2025

BeyondSpring stock hits 52-week low at $1.4 amid sharp decline By Investing.com - Investing.com South Africa

Mar 28, 2025

BeyondSpring stock hits 52-week low at $1.4 amid sharp decline - Investing.com

Mar 28, 2025

Mar 27, 2025